2
RATIONALE: OBJECTIVE: METHODS: RESULTS: CONCLUSIONS: PubMed Commons home Psychopharmacology (Berl). 2013 May;227(2):299-306. doi: 10.1007/s00213-013-2978-z. Epub 2013 Jan 26. Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults. Sathyanarayanan V , Thomas T , Einöther SJ, Dobriyal R, Joshi MK, Krishnamachari S. Abstract A number of studies have indicated positive effects of long-term administration (3 months) of Bacopa monniera (Brahmi) on various cognitive functions especially memory and anxiety. However, inconsistent results in literature may be linked to various methodological issues. The present study aimed to test the chronic effects (12 weeks) of 450 mg of a B. monniera (Brahmi) extract on learning and memory, information processing and anxiety in healthy adult Indian population. The study design was a randomised, double-blind, placebo-controlled parallel design. Participants comprised of 72 healthy urban adults, both men and women, in the age range of 35-60 years who were educated and English speaking with basic knowledge of computers from Bangalore. The outcome measures included verbal learning and memory, inspection time, attention and interference. State and trait anxiety were additional outcome variables. In the present study, there were no significant differences between the two groups on any of the cognitive measures. However, there was a trend for lower state anxiety in the B. monniera (Brahmi) group as compared to placebo group. The current study attempted to determine the chronic effects of single daily dose of 450 mg of Brahmi extract on cognitive performance and anxiety in healthy adults. The results of the current study are not in agreement with findings of some of the earlier studies which have found improvement both on cognitive parameters and a reduction of anxiety scores. PMID: 23354535 [PubMed - indexed for MEDLINE] PubMed Commons 0 comments Abstract 1 Author information Publication Types, MeSH Terms, Substances LinkOut - more resources PubMed Full text links Brahmi for the better? New findings challenging cognition... http://www.ncbi.nlm.nih.gov/pubmed/23354535 1 of 2 6/2/15 2:13 AM

Brahmi for the better? New findings challenging …accurateclinic.com/wp-content/uploads/2016/04/Brahmi-for-the...Title: Brahmi for the better? New findings challenging cognition and

Embed Size (px)

Citation preview

RATIONALE:

OBJECTIVE:

METHODS:

RESULTS:

CONCLUSIONS:

PubMed Commons home

Psychopharmacology (Berl). 2013 May;227(2):299-306. doi: 10.1007/s00213-013-2978-z. Epub 2013 Jan 26.

Brahmi for the better? New findings challenging cognition and anti-anxiety effectsof Brahmi (Bacopa monniera) in healthy adults.Sathyanarayanan V , Thomas T, Einöther SJ, Dobriyal R, Joshi MK, Krishnamachari S.

AbstractA number of studies have indicated positive effects of long-term administration (3 months) of

Bacopa monniera (Brahmi) on various cognitive functions especially memory and anxiety. However,inconsistent results in literature may be linked to various methodological issues.

The present study aimed to test the chronic effects (12 weeks) of 450 mg of a B. monniera(Brahmi) extract on learning and memory, information processing and anxiety in healthy adult Indianpopulation.

The study design was a randomised, double-blind, placebo-controlled parallel design. Participantscomprised of 72 healthy urban adults, both men and women, in the age range of 35-60 years who wereeducated and English speaking with basic knowledge of computers from Bangalore. The outcome measuresincluded verbal learning and memory, inspection time, attention and interference. State and trait anxiety wereadditional outcome variables.

In the present study, there were no significant differences between the two groups on any of thecognitive measures. However, there was a trend for lower state anxiety in the B. monniera (Brahmi) group ascompared to placebo group.

The current study attempted to determine the chronic effects of single daily dose of 450 mgof Brahmi extract on cognitive performance and anxiety in healthy adults. The results of the current study arenot in agreement with findings of some of the earlier studies which have found improvement both on cognitiveparameters and a reduction of anxiety scores.

PMID: 23354535 [PubMed - indexed for MEDLINE]

PubMed Commons

0 comments

Abstract

1

Author information

Publication Types, MeSH Terms, Substances

LinkOut - more resources

PubMed

Full text links

Brahmi for the better? New findings challenging cognition... http://www.ncbi.nlm.nih.gov/pubmed/23354535

1 of 2 6/2/15 2:13 AM

eemd
eemd

How to join PubMed Commons

Brahmi for the better? New findings challenging cognition... http://www.ncbi.nlm.nih.gov/pubmed/23354535

2 of 2 6/2/15 2:13 AM